BENTA disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:464336OMIM:616452D81.8
Who is this for?
Show terms as
1FDA treatments1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

BENTA disease stands for B-cell Expansion with NF-κB and T-cell Anergy. It is an extremely rare genetic disorder of the immune system caused by mutations in the CARD11 gene. This condition leads to an abnormal increase in a type of white blood cell called B cells, while at the same time the T cells (another important type of immune cell) do not work properly. The disease is present from birth or early infancy. People with BENTA disease typically have enlarged spleens (splenomegaly), swollen lymph nodes, and very high numbers of B cells in their blood. Because their immune system does not function correctly, they may be more prone to infections and may have a higher risk of developing certain blood cancers, particularly B-cell lymphoma, later in life. Some patients also experience allergies and other immune-related problems. There is currently no cure for BENTA disease. Treatment focuses on managing symptoms, preventing infections, and monitoring for signs of cancer. Doctors may use medications to support the immune system or reduce the number of abnormal B cells. Because the disease is so rare, treatment plans are often individualized based on each patient's specific symptoms and needs. Regular follow-up with immunology specialists is essential for long-term management.

Also known as:

Key symptoms:

Enlarged spleen (splenomegaly)Swollen lymph nodes throughout the bodyVery high numbers of B cells in the bloodFrequent or unusual infectionsT cells that do not respond properly to threatsEar infections that keep coming backAllergies or allergic-type reactionsFatigue and low energyIncreased risk of B-cell lymphomaPossible autoimmune problemsPoor antibody responses to vaccines

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

1 available

Cerezyme

IMIGLUCERASE· Genzyme Corporation■ Boxed WarningOrphan Drug

treatment of non-central nervous system (CNS) manifestations of Type 1 or Type 3 Gaucher disease in adults and pediatric patients

No actively recruiting trials found for BENTA disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the BENTA disease community →

Specialists

1 foundView all specialists →
FR
Frédéric Rieux-Laucat
Specialist
PI on 1 active trial12 BENTA disease publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to BENTA disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open BENTA diseaseForum →

No community posts yet. Be the first to share your experience with BENTA disease.

Start the conversation →

Latest news about BENTA disease

No recent news articles for BENTA disease.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How often should my child have blood tests and cancer screening?,Does my child need immunoglobulin replacement therapy or preventive antibiotics?,Are there any activities or sports my child should avoid because of an enlarged spleen?,What signs of infection or lymphoma should I watch for at home?,Should other family members be tested for the CARD11 mutation?,Are there any clinical trials or new treatments being studied for BENTA disease?,How will this condition affect my child's ability to attend school and participate in normal activities?

Common questions about BENTA disease

What is BENTA disease?

BENTA disease stands for B-cell Expansion with NF-κB and T-cell Anergy. It is an extremely rare genetic disorder of the immune system caused by mutations in the CARD11 gene. This condition leads to an abnormal increase in a type of white blood cell called B cells, while at the same time the T cells (another important type of immune cell) do not work properly. The disease is present from birth or early infancy. People with BENTA disease typically have enlarged spleens (splenomegaly), swollen lymph nodes, and very high numbers of B cells in their blood. Because their immune system does not func

How is BENTA disease inherited?

BENTA disease follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does BENTA disease typically begin?

Typical onset of BENTA disease is neonatal. Age of onset can vary across affected individuals.

Which specialists treat BENTA disease?

1 specialists and care centers treating BENTA disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.